Turning Gene Therapy Into Reality: Peter Marks, MD, PhD
March 20th 2023The director of the Center for Biologics Evaluation Research at the FDA provided an overview of the Keynote Address he gave at the 2023 Muscular Dystrophy Association Clinical and Scientific Conference. [WATCH TIME: 3 minutes]
The Patient Journey in the Management of Multiple Sclerosis
March 20th 2023In this program, we will discuss the management of Multiple Sclerosis (MS) from physician and patient perspectives. In particular, we will discuss a patient’s diagnosis journey, the importance of comprehensive care, and resources for the MS community.
Advances in the Management of Excessive Daytime Sleepiness and Narcolepsy
March 17th 2023In this program, sleep experts will discuss the importance of timely and accurate diagnosis, recent approvals and available treatment options for the management of narcolepsy and excessive daytime sleepiness.
Inebilizumab as a Treatment for NMOSD and Autoimmune Encephalitis: Gregory Day, MD, MSc, MSCI, FAAN
March 17th 2023The neurologist at Mayo Clinic, in Jacksonville, Florida, spoke about inebilizumab as a treatment for NMOSD and other autoimmune diseases, such as encephalitis, in the ExTINGUISH trial. [WATCH TIME: 3 minutes]
Importance of Establishing Healthy Eating Habits in Epilepsy: Orrin Devinsky, MD
March 16th 2023The director of the Comprehensive Epilepsy Center at NYU Langone discussed the importance of healthy eating habits and whether all individuals with epilepsy should consider dieting early in their life. [WATCH TIME: 4 minutes]
Evolution of NMOSD Research and Implications for Other Autoimmune Diseases: Michael Levy, MD, PhD
March 15th 2023In a recent interview, the associate professor at Harvard Medical School spoke about patient-centered research in the advancing treatment for patients with NMOSD. [WATCH TIME: 5 minutes]
Effect of HbA1c Elevation, Glycemic Control Following Mechanical Thrombectomy: David Baker, DO
March 15th 2023The vascular neurologist at Cleveland Clinic provided an overview of a study that assessed the extent HbA1c impacts the relationship between mechanical thrombectomy and poor outcomes. [WATCH TIME: 3 minutes]
Exploring New Therapies for MS With Research on T-bet+ memory B Cells: Rajiv Jain, PhD
March 14th 2023At the 2023 ACTRIMS, the post-doctoral associate in the department of clinical neurosciences at the University of Calgary, spoke on the impact of researching T-Bet+ memory B cells for new therapies in multiple sclerosis. [WATCH TIME: 5 minutes]
Planning for Headache on the Hill Through Community Outreach, Research: Julienne Verdi
March 13th 2023The executive director of the Alliance for Headache Disorders Advocacy provided perspective on the preparation that goes into Headache on the Hill, and the parties involved in this process. [WATCH TIME: 5 minutes]
Promising Findings on the Role of T-bet+ Memory B Cells in MS: Rajiv Jain, PhD
March 13th 2023At the 2023 ACTRIMS Forum, the post-doctoral associate in the department of clinical neurosciences at the University of Calgary talked about the main findings he observed with B cell therapies in patients with MS. [WATCH TIME: 4 minutes]
Gaining a Better Understanding of Metabolic Changes in Epilepsy From Dieting: Orrin Devinsky, MD
March 12th 2023The director of the Comprehensive Epilepsy Center at NYU Langone provided insight on a recently published study assessing the metabolic effects of short-term modified Atkins diet in patients with epilepsy. [WATCH TIME: 4 minutes]